These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
No fee required.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0‑11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0‑11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date Filed:
|
|
•
|
to elect three Class I members of the board of directors to serve until the 2017 annual meeting of stockholders;
|
|
•
|
to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014;
|
|
•
|
to approve the compensation awarded to our named executive officers in 2013 on an advisory basis; and
|
|
•
|
to transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|
|
|
Page
|
|
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be held on July 22, 2014
|
3
|
|
Questions and Answers About the 2014 Annual Meeting and Procedural Matters
|
3
|
|
Directors, Director Nominees, Executive Officers and Corporate Governance
|
8
|
|
Directors, Director Nominees and Executive Officers
|
8
|
|
Board Structure
|
10
|
|
Standing Committees of the Board of Directors
|
10
|
|
Risk Management
|
11
|
|
Board of Directors and Committee Meeting Attendance
|
12
|
|
Annual Meeting Attendance
|
12
|
|
Director Nomination Process and Qualifications
|
12
|
|
Director and Director Nominee Independence
|
14
|
|
Compensation Committee Interlocks and Insider Participation
|
14
|
|
Code of Business Conduct and Ethics
|
14
|
|
Director Compensation
|
15
|
|
Director Compensation Policies
|
15
|
|
2013 Director Compensation
|
16
|
|
Executive Compensation
|
17
|
|
Compensation Discussion and Analysis
|
17
|
|
Compensation Committee Report
|
32
|
|
Summary Compensation Table
|
33
|
|
Grants of Plan-Based Awards
|
34
|
|
Outstanding Equity Awards at Fiscal Year End
|
35
|
|
Option Exercises and Stock Vested Table
|
37
|
|
Potential Payments Upon Termination or a Change of Control
|
38
|
|
Compensation Risk Assessment
|
41
|
|
Certain Relationships and Related Transactions
|
42
|
|
Policies and Procedures for Transactions with Related Persons
|
42
|
|
Transactions and Relationships with Directors, Officers and Five Percent Stockholders
|
42
|
|
Security Ownership of Certain Beneficial Owners and Management
|
44
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
46
|
|
Principal Accounting Fees and Services
|
47
|
|
Audit and Related Fees for Fiscal Years 2012 and 2013
|
47
|
|
Pre-Approval Policies and Procedures
|
47
|
|
Audit Committee Report
|
48
|
|
Proposals To Be Voted On
|
49
|
|
Proposal No. 1: Election of Directors
|
49
|
|
Proposal No. 2: Ratification of Appointment of Independent Registered Public Accounting Firm
|
50
|
|
Proposal No. 3: Advisory Vote on Named Executive Officer Compensation
|
51
|
|
Other Information
|
52
|
|
Q:
|
Why am I receiving these proxy materials?
|
|
A:
|
The Board of Directors of comScore, Inc. (the “Company,” “comScore,” “we,” “us” or “our”) has made these proxy materials available to you on the Internet, or is providing printed proxy materials to you, in connection with the solicitation of proxies for use at comScore’s 2014 Annual Meeting of Stockholders (the “2014 Annual Meeting”) to be held Tuesday, July 22, 2014, at 2:15 p.m., Eastern Time, and at any adjournment or postponement thereof, for the purpose of considering and acting upon the matters set forth in this proxy statement. These proxy materials are being made available or distributed to you on or about June 12, 2014. As a stockholder, you are invited to attend the 2014 Annual Meeting and are requested to vote on the proposals described in this proxy statement.
|
|
Q:
|
Where is the 2014 Annual Meeting?
|
|
A:
|
The 2014 Annual Meeting will be held at the Company's offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190.
|
|
Q:
|
Can I attend the 2014 Annual Meeting?
|
|
A:
|
You are invited to attend the 2014 Annual Meeting if you were a stockholder of record or a beneficial owner as of June 6, 2014 (the “Record Date”). You should bring photo identification and your Notice of Internet Availability, a statement from your broker, or other proof of stock ownership as of the Record Date, for entrance to the 2014 Annual Meeting. The meeting will begin promptly at 2:15 p.m., Eastern Time and you should leave ample time for check-in procedures. We will not be able to accommodate guests who were not stockholders as of the Record Date at the 2014 Annual Meeting.
|
|
Q:
|
Who is entitled to vote at the 2014 Annual Meeting?
|
|
A:
|
You may vote your shares of comScore common stock if our records show that you owned your shares at the close of business on the Record Date. At the close of business on the Record Date, there were 36,100,708.000 shares of comScore common stock outstanding and entitled to vote at the 2014 Annual Meeting. You may cast one vote for each share of common stock held by you as of the Record Date on all matters presented.
As of the Record Date, holders of common stock are eligible to cast an aggregate of 36,100,708.000 votes at the 2014 Annual Meeting.
|
|
Q:
|
What is the difference between holding shares as a stockholder of record or as a beneficial owner?
|
|
A:
|
If your shares are registered directly in your name with comScore’s transfer agent, American Stock Transfer & Trust Company, you are considered, with respect to those shares, the “stockholder of record,” and the Notice of Internet Availability has been sent directly to you by comScore. As the stockholder of record, you have the right to grant your voting proxy directly to comScore or to a third party, or to vote in person at the 2014 Annual Meeting.
If your shares are held by a brokerage account or by a bank or another nominee, you are considered the “beneficial owner” of shares held in “street name,” and the Notice of Internet Availability has been forwarded to you by your broker, trustee or nominee who is considered, with respect to those shares, the stockholder of record. As a beneficial owner, you have the right to direct your broker, trustee or nominee how to vote your shares. Please refer to the voting instruction card provided by your broker, trustee or nominee. You are also invited to attend the 2014 Annual Meeting.
However, because a beneficial owner is not the stockholder of record, you may not vote these shares in person at the 2014 Annual Meeting unless you obtain a “legal proxy” from the broker, trustee or nominee that holds your shares, giving you the right to vote the shares at the 2014 Annual Meeting.
|
|
Q:
|
How can I vote my shares in person at the 2014 Annual Meeting?
|
|
A:
|
Shares held in your name as the stockholder of record may be voted in person at the 2014 Annual Meeting. Shares held beneficially in street name may be voted in person at the 2014 Annual Meeting only if you obtain a “legal proxy” from the broker, trustee or nominee that holds your shares giving you the right to vote the shares.
Even if you plan to attend the 2014 Annual Meeting, we recommend that you also submit your vote as instructed on the Notice of Internet Availability and below, so that your vote will be counted even if you later decide not to attend the 2014 Annual Meeting
.
|
|
Q:
|
How can I vote my shares without attending the 2014 Annual Meeting?
|
|
A:
|
Whether you hold shares directly as the stockholder of record or beneficially in street name, you may direct how your shares are voted without attending the 2014 Annual Meeting. If you are a stockholder of record, you may vote by submitting a proxy. If you hold shares beneficially in street name, you may vote by submitting voting instructions to your broker, trustee or nominee. For instructions on how to vote, please refer to the instructions below and those included on the Notice of Internet Availability or, for shares held beneficially in street name, the voting instructions provided to you by your broker, trustee or nominee.
By Internet
- Stockholders of record of comScore common stock with Internet access may submit proxies by following the “Vote by Internet” instructions on the Notice of Internet Availability until 2:15pm, Eastern Time on July 22, 2014. If you are a beneficial owner of comScore common stock held in street name, please check the voting instructions provided by your broker, trustee or nominee for Internet voting availability.
By mail
- Stockholders of record of comScore common stock may request a paper proxy card from comScore by following the procedures outlined in the Notice of Internet Availability. If you elect to vote by mail, please indicate your vote by completing, signing and dating the proxy card where indicated and by returning it in the prepaid envelope that will be included with the proxy card. Proxy cards submitted by mail must be received by the time of the meeting in order for your shares to be voted. comScore stockholders who hold shares beneficially in street name may vote by mail by completing, signing and dating the voting instructions provided by their brokers, trustees or nominees and mailing them in the accompanying pre-addressed envelopes.
|
|
Q:
|
How many shares must be present or represented to conduct business at the 2014 Annual Meeting?
|
|
A:
|
The presence of the holders of a majority of the shares entitled to vote at the 2014 Annual Meeting is necessary to constitute a quorum at the 2014 Annual Meeting. Such stockholders are counted as present at the meeting if (1) they are present in person at the 2014 Annual Meeting or (2) have properly submitted a proxy.
Under the General Corporation Law of the State of Delaware, abstentions and broker non-votes are counted as present and entitled to vote and are, therefore, included for the purposes of determining whether a quorum is present at the 2014 Annual Meeting.
A “broker non-vote” occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item and has not received voting instructions from the beneficial owner.
|
|
Q:
|
What proposals will be voted on at the 2014 Annual Meeting?
|
|
A:
|
The proposals scheduled to be voted on at the 2014 Annual Meeting are:
|
|
|
(1) The election of the three Class I directors listed in this proxy statement to serve until the 2017 annual meeting of stockholders;
(2) The ratification of the appointment of Ernst & Young LLP as comScore’s independent registered public accounting firm for the fiscal year ending December 31, 2014; and
(3) The approval of the compensation awarded to our named executive officers in 2013 on an advisory basis.
|
|
Q:
|
What is the voting requirement to approve each of the proposals?
|
|
A:
|
Proposal
|
Vote Required
|
Broker Discretionary Voting Allowed
|
|
|
Proposal One - Election of three Class I directors
|
Plurality of Votes Cast
|
No
|
|
|
Proposal Two - Ratification of the appointment of independent registered public accounting firm
|
Majority of the Shares Entitled to Vote and Present in Person or Represented by Proxy
|
Yes
|
|
|
Proposal Three - Approval of 2013 named executive officer compensation on an advisory basis
|
Majority of the Shares Entitled to Vote and Present in Person or Represented by Proxy
|
No
|
|
Q:
|
How are votes counted?
|
|
A:
|
You may vote “FOR” or “WITHHOLD” on each of the nominees for election as director (Proposal One). The three nominees for director receiving the highest number of affirmative votes will be elected as directors.
You may vote “FOR,” “AGAINST” or “ABSTAIN” on the proposals to ratify the appointment of Ernst & Young LLP as comScore’s independent registered public accounting firm (Proposal Two) and to approve, by non-binding vote, executive compensation (Proposal Three).
Abstentions are deemed to be votes cast and have the same effect as a vote against these proposals.
All shares entitled to vote and represented by properly executed proxies received prior to the 2014 Annual Meeting (and not revoked) will be voted at the 2014 Annual Meeting in accordance with the instructions indicated.
|
|
Q:
|
What if I do not specify how my shares are to be voted?
|
|
A:
|
You may vote “FOR” or “WITHHOLD” on each of the nominees for election as director (Proposal One). The three nominees for director receiving the highest number of affirmative votes will be elected as directors. Therefore, abstentions will not affect the outcome of the election.
If you are a stockholder of record and you submit a proxy, but you do not provide voting instructions, your shares will be voted as recommended by the Board of Directors.
If you are a beneficial owner and you do not provide the broker or other nominee that holds your shares with voting instructions, the broker or other nominee will determine if it has the discretionary authority to vote on the particular matter. Under applicable regulations, brokers and other nominees have the discretion to vote on routine matters such as Proposal two but do not have discretion to vote on Proposal Three. Therefore, if you do not provide voting instructions to your broker or other nominee, your broker or other nominee may only vote your shares on Proposal Two and any other routine matters properly presented for a vote at the 2014 Annual Meeting.
|
|
Q:
|
What is the effect of a broker non-vote?
|
|
A:
|
Brokers or other nominees who hold shares of comScore’s common stock for a beneficial owner have the discretion to vote on routine proposals when they have not received voting instructions from the beneficial owner at least ten days prior to the 2014 Annual Meeting. A broker non-vote occurs when a broker or other nominee does not receive voting instructions from the beneficial owner and does not have the discretion to direct the voting of the shares. Broker non-votes will be counted for purposes of calculating whether a quorum is present at the 2014 Annual Meeting, but will not be counted for purposes of determining the number of votes present in person or represented by proxy and entitled to vote with respect to a particular proposal. Thus, a broker non-vote will not impact our ability to obtain a quorum and will not otherwise affect the outcome of the vote on a proposal that requires a plurality of votes cast (Proposal One) or the approval of a majority of the votes present in person or represented by proxy and entitled to vote (Proposal Three).
|
|
Q:
|
What is the effect of not casting a vote at the 2014 Annual Meeting?
|
|
A:
|
If you are the stockholder of record of your shares and you do not vote by proxy card, via the Internet or in person at the 2014 Annual Meeting, your shares will not be voted at the 2014 Annual Meeting.
If you are a beneficial owner of shares held in street name, it is critical that you provide voting instructions if you want it to count in the election of directors (Proposal One) or the non-binding vote on executive compensation (Proposal Three).
In the past, if you held your shares in street name and you did not indicate how you wanted your shares voted in the election of directors, your bank or broker was allowed to vote those shares on your behalf in the election of directors as they felt appropriate. Under applicable regulations, your bank or broker does not have the ability to vote your uninstructed shares in the election of directors on a discretionary basis or to vote your uninstructed shares in non-binding proposals related to executive compensation. Thus, if you hold your shares in street name and you do not instruct your bank or broker how to vote in these matters, no votes will be cast on your behalf. Your bank or broker will, however, continue to have discretion to vote any uninstructed shares on the ratification of the appointment of comScore’s independent registered public accounting firm (Proposal Two).
|
|
Q:
|
How does the Board of Directors recommend that I vote?
|
|
A:
|
The Board of Directors recommends that you vote your shares:
|
|
|
“
FOR
” the three nominees for election as directors (Proposal One);
“
FOR
” the ratification of the appointment of Ernst & Young LLP as comScore’s independent registered public accounting firm for the fiscal year ending December 31, 2014 (Proposal Two); and
“
FOR
” the approval, by non-binding vote, of executive compensation (Proposal Three).
|
|
Q:
|
What happens if additional matters are presented at the 2014 Annual Meeting?
|
|
A.
|
If any other matters are properly presented for consideration at the 2014 Annual Meeting, including, among other things, consideration of a motion to adjourn the 2014 Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting additional proxies), the persons named as proxy holders, Magid M. Abraham and Serge Matta, or either of them, will have discretion to vote on those matters in accordance with their best judgment. comScore does not currently anticipate that any other matters will be raised at the 2014 Annual Meeting.
|
|
Q:
|
Can I change my vote?
|
|
A:
|
Subject to any rules your broker, trustee or nominee may have, you may change your proxy instructions at any time before your proxy is voted at the 2014 Annual Meeting.
If you are the stockholder of record, you may change your vote (1) by granting a new proxy bearing a later date (which automatically revokes the earlier proxy) using any of the voting methods described above (and until the applicable deadline for each voting method), (2) by providing a written notice of revocation to comScore’s Corporate Secretary at comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190 prior to your shares being voted, or (3) by attending the 2014 Annual Meeting and voting in person. Attendance at the meeting will not cause your previously granted proxy to be revoked unless you specifically so request.
If you are a beneficial owner of shares held in street name, you may change your vote by (1) submitting new voting instructions to your broker, trustee or nominee or (2) if you have obtained a legal proxy from the broker, trustee or nominee that holds your shares giving you the right to vote your shares, by attending the 2014 Annual Meeting and voting in person.
|
|
Q:
|
What happens if I decide to attend the 2014 Annual Meeting, but I have already voted or submitted a proxy card covering my shares?
|
|
A:
|
Subject to any rules your broker, trustee or nominee may have, you may attend the 2014 Annual Meeting and vote in person even if you have already voted or submitted a proxy card. Any previous votes that were submitted by you will be superseded by the vote you cast at the 2014 Annual Meeting. Please be aware that attendance at the 2014 Annual Meeting will not, by itself, revoke a proxy.
If a broker, trustee or nominee beneficially holds your shares in street name and you wish to attend the 2014 Annual Meeting and vote in person, you must obtain a legal proxy from the broker, trustee or nominee that holds your shares giving you the right to vote the shares.
|
|
Q:
|
What should I do if I receive more than one Notice of Internet Availability or set of proxy materials?
|
|
A:
|
You may receive more than one Notice of Internet Availability or set of proxy materials, including multiple copies of proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you may receive a separate Notice of Internet Availability or voting instruction card for each brokerage account in which you hold shares. If you are a stockholder of record and your shares are registered in more than one name, you will receive more than one Notice of Internet Availability or proxy card. Please complete, sign, date and return each comScore proxy card or voting instruction card that you receive to ensure that all your shares are voted.
|
|
Q:
|
Who will count the votes?
|
|
A:
|
comScore’s board of directors has designated representatives of Wilson Sonsini Goodrich & Rosati, the Company’s outside counsel, to serve as inspector of election.
|
|
Q:
|
Where can I find the voting results of the 2014 Annual Meeting?
|
|
A:
|
We intend to announce preliminary voting results at the 2014 Annual Meeting and will publish final results in our Current Report on Form 8-K, which will be filed with the SEC within four (4) business days following the 2014 Annual Meeting.
|
|
Q:
|
Who will bear the cost of soliciting votes for the 2014 Annual Meeting?
|
|
A:
|
comScore will pay the entire cost of preparing, assembling, printing, mailing and distributing these proxy materials and soliciting votes. We may reimburse brokerage firms, custodians, nominees, fiduciaries and other persons representing beneficial owners for their reasonable expenses in forwarding solicitation material to such beneficial owners. Our directors, officers and employees may also solicit proxies in person or by other means of communication. Such directors, officers and employees will not be additionally compensated but may be reimbursed for reasonable out-of-pocket expenses in connection with such solicitation.
If you choose to access the proxy materials and/or vote over the Internet, you are responsible for Internet access charges you may incur.
|
|
Q:
|
What is the deadline to propose actions for consideration at next year's annual meeting of stockholders or to nominate individuals to serve as directors?
|
|
A:
|
You may submit proposals, including recommendations of director candidates, for consideration at future stockholder meetings.
comScore’s bylaws provide for advance notice procedures to recommend a person for nomination as a director or to propose business to be considered by stockholders at a meeting. For the 2015 annual meeting of stockholders, such nominations or proposals, other than those made by or at the direction of the board of directors, must be submitted in writing and received by our Corporate Secretary at our offices no later than March 14, 2015, which is 90 days prior to the anniversary of the expected first mailing date of notice of availability of this proxy statement. If our 2015 annual meeting of stockholders is moved more than 30 days before or after the anniversary date of our 2014 Annual Meeting, then the deadline is the close of business on the tenth day following the day notice of the date of the meeting was mailed or made public, whichever occurs first. Such proposals also must comply with all applicable requirements of the rules and regulations of the SEC. The chairperson of the stockholder meeting may refuse to acknowledge the introduction of your proposal if it is not made in compliance with the foregoing procedures or the applicable provisions of our bylaws. If a stockholder who has notified comScore of his or her intention to present a proposal at an annual meeting does not appear to present his or her proposal at such meeting, comScore need not present the proposal for vote at such meeting.
In addition, for a stockholder proposal to be considered for inclusion in our proxy statement for the 2015 annual meeting of stockholders, the proposal must be submitted in writing and received by our Corporate Secretary at our offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190 no later than February 12, 2015, which is 120 days prior to the anniversary of the expected mailing date of the notice of availability of this proxy statement.
A copy of the full text of the bylaw provisions discussed above may be obtained by writing to comScore’s Corporate Secretary at our principal executive offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190 or by accessing comScore’s filings on the SEC’s website at www.sec.gov. All notices of proposals by stockholders, whether or not included in comScore’s proxy materials, should be sent to comScore’s Corporate Secretary at our principal executive offices.
|
|
Q:
|
How may I obtain a separate copy of the Notice of Internet Availability?
|
|
A:
|
If you share an address with another stockholder, each stockholder may not receive a separate copy of the Notice of Internet Availability. Stockholders may request to receive separate or additional copies of the Notice of Internet Availability by writing to comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Investor Relations. Stockholders who share an address and receive multiple copies of the Notice of Internet Availability can also request to receive a single copy by following the instructions above.
|
|
Q:
|
How may I obtain comScore’s 2013 Form 10-K and other financial information?
|
|
A:
|
Stockholders can access our 2013 Form 10-K, and other financial information on our website at www.comscore.com under the caption “Investors” or on the Securities and Exchange Commission's website at www.sec.gov. Alternatively, current and prospective investors may request a free copy of our 2013 Form 10-K, from: comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Investor Relations. We also will furnish any exhibit to the 2013 Form 10-K if specifically requested upon payment of charges that approximate our cost of reproduction.
|
|
Q:
|
Who can help answer my questions?
|
|
A:
|
Please contact our legal department by calling 703-438-2000 or by writing to comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Legal Department.
|
|
Name
|
Age
|
Position
|
|
Executive Officers and Executive Directors
|
|
|
|
Serge Matta
|
39
|
President, Chief Executive Officer and Class III Director
|
|
Magid M. Abraham, Ph.D.
|
55
|
Executive Chairman of the Board of Directors and Class I Director
|
|
Gian M. Fulgoni
|
66
|
Chairman Emeritus and Class III Director
|
|
Kenneth J. Tarpey(1)
|
61
|
Chief Financial Officer
|
|
Cameron Meierhoefer
|
42
|
Chief Operating Officer
|
|
Christiana L. Lin
|
44
|
Executive Vice President, General Counsel and Chief Privacy Officer
|
|
|
|
|
|
Non-Executive Directors
|
|
|
|
Jeffrey Ganek(3)
|
61
|
Class III Director
|
|
William J. Henderson(3)(4)
|
66
|
Class II Director
|
|
William Katz(2)(4)
|
59
|
Class I Director
|
|
Ronald J. Korn(3)
|
73
|
Class II Director
|
|
Jarl Mohn(2)(4)(5)
|
62
|
Class I Director
|
|
|
|
|
|
Non-Executive Director Nominees
|
|
|
|
Russell Fradin
|
37
|
Class I Director Nominee
|
|
(1)
|
As announced on May 8, 2014, Mr. Tarpey intends to retire from his position as Chief Financial Officer. Mr. Tarpey has agreed to continue to serve as Chief Financial Officer until the filing date of our quarterly report on Form 10-Q for the quarter ended June 30, 2014 (but in no event later than August 15, 2014). Mr. Tarpey has also agreed to assist with transitioning the position and duties of the chief financial officer.
|
|
(2)
|
Member of nominating and governance committee
|
|
(3)
|
Member of audit committee
|
|
(4)
|
Member of compensation committee
|
|
(5)
|
Mr. Mohn will not be standing for re-election at the 2014 Annual Meeting
|
|
•
|
the name, age, business address and residence address of the proposed candidate;
|
|
•
|
the principal occupation or employment of the proposed candidate;
|
|
•
|
the class and number of shares of our stock that the proposed candidate beneficially owns;
|
|
•
|
a description of all arrangements or understandings between the stockholder making the recommendations and each director nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the stockholder; and
|
|
•
|
any other information relating to such director candidate that is required to be disclosed in solicitations of proxies for elections of directors or is otherwise required pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (including without limitation such nominee’s written consent to being named in any proxy statement as a nominee and to serve as a director if elected).
|
|
•
|
a high degree of personal and professional integrity;
|
|
•
|
commitment to promoting the long term interests of our stockholders;
|
|
•
|
broad general business experience and acumen, which may include experience in management, finance, marketing and accounting, with particular emphasis on technology companies;
|
|
•
|
adequate time to devote attention to the affairs of our company;
|
|
•
|
an ability to bring balance to our board of directors in light of our company’s current and anticipated needs and in light of the skills and attributes of the other board members; and
|
|
•
|
other attributes relevant to satisfying the requirements imposed by the SEC and NASDAQ.
|
|
|
|
2013
|
||||||
|
Committee
|
|
Chairperson
|
|
Member
|
||||
|
Audit
|
|
$
|
18,000
|
|
|
$
|
10,000
|
|
|
Compensation
|
|
10,000
|
|
|
5,000
|
|
||
|
Nominating and Governance
|
|
7,500
|
(1)
|
|
3,000
|
(1)
|
||
|
(1)
|
In February 2013, after review of director compensation in comparison to our compensation peer group, the retainers paid to the members and chairperson of our Nominating and Governance Committee were found to be below the median of the competitive market. Therefore, the Board determined to increase the annual cash retainer to $7,500 for the Nominating and Governance Committee chair and $3,000 for the Nominating and Governance Committee members, to be paid on a prorated basis covering service remaining prior to our July 2013 Annual Meeting of Stockholders.
|
|
Name
|
|
Fees Earned or Paid in Cash ($)(2)
|
|
Stock Awards ($)(1)(2)
|
|
Total ($)(2)
|
|
Gareth Chang(3)
|
|
28,000
|
|
14,576
|
|
42,576
|
|
Jeffrey Ganek
|
|
40,000
|
|
139,600
|
|
179,600
|
|
William J. Henderson
|
|
50,000
|
|
139,600
|
|
189,600
|
|
William Katz
|
|
37,500
|
|
139,600
|
|
177,100
|
|
Ronald J. Korn
|
|
48,000
|
|
139,600
|
|
187,600
|
|
Jarl Mohn
|
|
37,500
|
|
139,600
|
|
177,100
|
|
(1)
|
Represents the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of the stock awards granted to the non-employees in 2013. The assumptions used in the calculation of these award amounts are included in Note 10 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2013.
|
|
(2)
|
In February 2013, the Board amended our director compensation policy to increase the annual cash retainer, equity-based compensation, and the cash retainers for the Nominating and Governance Committee chair and its members, as described above. The amounts reported in this table reflect these increases.
|
|
(3)
|
Mr. Chang did not stand for reelection at the end of his term in July 2013.
|
|
Name
|
|
Award Type
|
|
Grant Date
|
|
Number of Shares
|
|
Grant Date Fair Value($)(1)
|
|
Gareth Chang(2)
|
|
Restricted Stock
|
|
February 18, 2013
|
|
897
|
|
14,576
|
|
Jeffrey Ganek
|
|
Restricted Stock
|
|
February 18, 2013
|
|
897
|
|
14,576
|
|
Jeffrey Ganek
|
|
Restricted Stock
|
|
July 23, 2013
|
|
4,725
|
|
125,024
|
|
William J. Henderson
|
|
Restricted Stock
|
|
February 18, 2013
|
|
897
|
|
14,576
|
|
William J. Henderson
|
|
Restricted Stock
|
|
July 23, 2013
|
|
4,725
|
|
125,024
|
|
William Katz
|
|
Restricted Stock
|
|
February 18, 2013
|
|
897
|
|
14,576
|
|
William Katz
|
|
Restricted Stock
|
|
July 23, 2013
|
|
4,725
|
|
125,024
|
|
Ronald J. Korn
|
|
Restricted Stock
|
|
February 18, 2013
|
|
897
|
|
14,576
|
|
Ronald J. Korn
|
|
Restricted Stock
|
|
July 23, 2013
|
|
4,725
|
|
125,024
|
|
Jarl Mohn
|
|
Restricted Stock
|
|
February 18, 2013
|
|
897
|
|
14,576
|
|
Jarl Mohn
|
|
Restricted Stock
|
|
July 23, 2013
|
|
4,725
|
|
125,024
|
|
(1)
|
In February 2013, the Board amended our director compensation policy to increase the equity-based compensation for our non-employee directors as described above. The February 2013 stock awards reported in this table reflects the pro rated portion of this increase.
|
|
(2)
|
Mr. Chang did not stand for reelection at the end of his term in July 2013.
|
|
•
|
Magid M. Abraham, Chief Executive Officer (our “CEO”);
|
|
•
|
Serge Matta, President;
|
|
•
|
Gian M. Fulgoni, Executive Chairman of our board of directors (our “Executive Chairman”);
|
|
•
|
Kenneth J. Tarpey, Chief Financial Officer; and
|
|
•
|
Cameron Meierhoefer, Chief Operating Officer.
|
|
•
|
Base salary, which was paid almost entirely in the form of restricted shares of our common stock in lieu of cash, and which was maintained without increase from our CEO's 2012 base salary;
|
|
•
|
There was no short-term incentive planned for, or made, in 2013;
|
|
•
|
Long-term incentive made in the form of vesting of the second tranche of a 3-year performance-based equity award granted in 2012, and whose amount was based on the achievement of pre-established 2013 company performance objectives; and
|
|
•
|
Certain welfare benefits, including health and dental insurance, life insurance, short-term and long-term disability insurance, and a 401(k) plan.
|
|
▪
|
In 2012, when we made substantial investments in our digital business analytics strategy, thereby emphasizing the creation of sustainable long-term growth at the expense of short-term returns,
we did not meet our revenue and adjusted EBITDA objectives for the year. Accordingly, Dr. Abraham earned no shares from the first installment of his performance-based equity award for the year. In addition, he saw the value of the initial installment of his retention-based equity award decrease in value by 37%
during the course of the year.
|
|
▪
|
In 2013, with our strong financial performance for the year, as reflected by our achievement of 134% of our revenue objective and 200% of our adjusted EBITDA objective for the year, Dr. Abraham earned 165% of the second installment of his performance-based equity award (including both performance-based bonus achievement and overachievement). Due to an increase in stock price during the course of year, the value of the performance- and time-based equity that vested in 2013 increased an additional 77%.
|
|
•
|
Attract and Retain Top Talent.
Our compensation arrangements should be sufficient to allow us to attract, retain and motivate named executive officers with the necessary skills and talent to successfully manage our business, taking into consideration a number of factors such as market studies, experience, alternative market opportunities, and consistency with the compensation paid to other professionals within our organization.
|
|
•
|
Promote Business Performance Accountability.
Compensation should be tied, in part, to the performance of the portion of the business for which a named executive officer is responsible and how that named executive officer’s business unit or area performs and contributes to our overall financial performance.
|
|
•
|
Promote Individual Performance Accountability.
Compensation should be tied, in part, to the individual named executive officer’s performance to encourage and reflect individual contributions to our overall business performance.
|
|
•
|
Align Stockholder Interests.
Compensation should be tied to our financial performance, in part, through equity awards, which help to align our named executive officers’ interests with those of our stockholders.
|
|
•
|
develop a culture that embodies a passion for our business and a drive to achieve and exceed established goals and objectives;
|
|
•
|
provide leadership to the organization in such a way as to maximize the results of our business operations;
|
|
•
|
lead us by demonstrating forward thinking in the operation, development and expansion of our business; and
|
|
•
|
effectively manage organizational resources to derive the greatest value possible from each dollar invested.
|
|
•
|
regularly reviews the performance of and the total compensation earned by or awarded to our CEO and Executive Chairman independent of input from them;
|
|
•
|
examines on an annual basis the performance of our other named executive officers with assistance from our CEO and Executive Chairman and approves total compensation packages for them that it believes to be consistent with those generally found in the marketplace for executives in comparable positions;
|
|
•
|
regularly holds executive sessions of compensation committee without management present; and
|
|
•
|
engages a compensation consultant to review our executive compensation policies and practices and provide analysis of the competitive market for our named executive officers in connection with setting their base salaries and equity-award levels.
|
|
(i)
|
how much we would be willing to pay to retain that named executive officer;
|
|
(ii)
|
how much we would expect to pay in the marketplace to replace that named executive officer; and
|
|
(iii)
|
how much that named executive officer could otherwise command in the employment marketplace.
|
|
Arbitron
Constant Contact Costar Group
Dice Holdings
Forrester Research
Kenexa
|
Liquidity Services
LogMeIn MicroStrategy
OpenTable
QuinStreet
Rentrak
|
Responsys
Synchronoss Technologies
The Active Network
ValueClick
Vocus
|
|
Name and Principal Position
|
2012
|
2013(1)
|
Percentage Change
|
|||||
|
Magid M. Abraham, Ph.D.
Chief Executive Officer and Director
|
$
|
500,000
|
|
$
|
500,000
|
(2)
|
0.0
|
%
|
|
Serge Matta
President
|
335,000
|
|
415,000
|
(2)
|
24.0
|
%
|
||
|
Gian M. Fulgoni
Executive Chairman of the Board of Directors
|
375,000
|
|
375,000
|
(2)
|
0.0
|
%
|
||
|
Kenneth J. Tarpey
Chief Financial Officer
|
350,000
|
|
367,500
|
|
10.9
|
%
|
||
|
Cameron Meierhoefer
Chief Operating Officer
|
300,000
|
|
321,000
|
|
7.0
|
%
|
||
|
(1)
|
All base salary adjustments amounts were effective on April 1, 2013.
|
|
(2)
|
For the period from January 1, 2013 through December 31, 2013, in lieu of receiving a cash salary, each of Dr. Abraham and Mr. Fulgoni received an award of shares of our common stock with a value equal to the amount of salary foregone by each, less amounts paid to them in cash during 2013 to cover health benefits, based on the closing price of our common stock as reported on the NASDAQ Global Market at the close of trading on October 31, 2013 for the first three calendar quarters in 2013, and on December 31, 2013 for the fourth calendar quarter in 2013. The number of shares of our common stock delivered to each named executive officer reduced by the number of shares necessary to satisfy applicable tax withholding requirements.
|
|
(3)
|
In June 2013, Mr. Matta was promoted to President, and his base salary was increased to $415,000 in this new role.
|
|
•
|
a short-term performance-based equity award in the form of shares of our common stock to be earned based on our performance in 2013;
|
|
•
|
a long-term performance-based award in the form of shares of shares of our common stock and restricted stock units to be earned based on 2013 annual performance and to vest in three equal annual increments in February 2014, 2015 and 2016; and
|
|
•
|
a long-term time-based equity award in the form of restricted stock units to be earned in three equal annual increments in February 2014, 2015 and 2016.
|
|
|
Value of Short-Term Performance-Based Stock Bonus Level for Annual Performance at Time of Grant(1)
|
|
Value of Long-Term Performance-Based Stock Bonus Level for Annual Performance at Time of Grant(1)
|
Value of Long-Term Time-Based Incentive at Time of Grant(1)
|
One-Time Restricted Stock Unit Award
|
|||||||||||||||||||
|
Name and Principal Position
|
Target
|
Maximum
|
Actual
|
|
Target
|
Maximum
|
Actual
|
|||||||||||||||||
|
Serge Matta*
President
|
$
|
415,000
|
|
$
|
830,000
|
|
$
|
604,374
|
|
|
$
|
300,000
|
|
$
|
600,000
|
|
$
|
600,000
|
|
$
|
600,000
|
|
50,000
|
|
|
Gian M. Fulgoni
Executive Chairman of the Board of Directors
|
375,000
|
|
750,000
|
|
470,357
|
|
|
275,000
|
|
500,000
|
|
500,000
|
|
500,000
|
|
25,000
|
|
|||||||
|
Kenneth J. Tarpey
Chief Financial Officer
|
275,625
|
|
551,250
|
|
336,617
|
|
|
150,000
|
|
300,000
|
|
300,000
|
|
300,000
|
|
25,000
|
|
|||||||
|
Cameron Meierhoefer
Chief Operating Officer
|
240,750
|
|
481,500
|
|
222,754
|
|
|
150,000
|
|
300,000
|
|
300,000
|
|
300,000
|
|
25,000
|
|
|||||||
|
(1)
|
Amounts represent the cash value of the shares issued as measured based on the closing price of our common stock reported on the NASDAQ Global Select Market at the date of grant. The shares actually awarded for each were as follows:
|
|
Name
|
Short-Term Performance-Based Stock Bonus Shares Awarded
|
Long-Term Performance-Based Stock Bonus Shares Awarded
|
Long-Term Time-Based Incentive Shares Awarded
|
|||
|
Serge Matta
|
18,964
|
|
18,826
|
|
18,826
|
|
|
Gian M. Fulgoni
|
14,759
|
|
17,258
|
|
17,258
|
|
|
Kenneth J. Tarpey
|
10,562
|
|
9,413
|
|
9,413
|
|
|
Cameron Meierhoefer
|
6,989
|
|
9,413
|
|
9,413
|
|
|
Achievement of
|
Min.
|
|
Target
|
|
Max.
|
|
Weight of Component as part Short-Term Performance-Based Stock Bonus
|
||||||||||||||||||
|
|
Abraham
|
|
Tarpey
|
|
Fulgoni
|
|
Matta
|
|
Meierhoefer
|
||||||||||||||||
|
|
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Target milestones for 2013 earnings before interest taxes, depreciation and amortization, or adjusted EBITDA
|
$
|
45.00
|
|
|
$
|
50.00
|
|
|
$
|
60.00
|
|
|
50
|
%
|
|
0
|
%
|
|
0
|
%
|
|
0%
|
|
0
|
%
|
|
Target milestones for 2013 revenue
|
$
|
264.4
|
|
|
$
|
278.3
|
|
|
$
|
295.0
|
|
|
50
|
%
|
|
80
|
%
|
|
80
|
%
|
|
30%
|
|
0
|
%
|
|
Individual qualitative factors
|
N/A
|
|
N/A
|
|
N/A
|
|
0
|
%
|
|
20
|
%
|
|
20
|
%
|
|
70%
|
|
100
|
%
|
||||||
|
Achievement of
|
Min.
|
|
Target
|
|
Max.
|
|
Weight of Component as part Long-Term Performance-Based Stock Bonus
|
||||||||||||||||||
|
|
Abraham
|
|
Tarpey
|
|
Fulgoni
|
|
Matta
|
|
Meierhoefer
|
||||||||||||||||
|
|
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Target milestones for 2013 earnings before interest taxes, depreciation and amortization, or adjusted EBITDA
|
$
|
45.00
|
|
|
$
|
50.00
|
|
|
$
|
60.00
|
|
|
0
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100%
|
|
100
|
%
|
|
|
Percentage Achieved in 2013
|
||||||||||
|
Name
|
EBITDA Achievement
|
|
Revenue Achievement
|
|
Qualitative Performance
|
|
Total Short- and Long-Term Bonus as Compared to Target
|
||||
|
Magid M. Abraham, Ph.D.
|
200
|
%
|
|
134
|
%
|
|
N/A
|
|
|
168
|
%
|
|
Kenneth J. Tarpey
|
200
|
%
|
|
134
|
%
|
|
74
|
%
|
|
129
|
%
|
|
Gian M. Fulgoni
|
200
|
%
|
|
134
|
%
|
|
100
|
%
|
|
131
|
%
|
|
Serge Matta
|
200
|
%
|
|
134
|
%
|
|
153
|
%
|
|
137
|
%
|
|
Cameron Meierhoefer
|
200
|
%
|
|
N/A
|
|
|
93
|
%
|
|
119
|
%
|
|
•
|
health and dental insurance;
|
|
•
|
life insurance;
|
|
•
|
short-and long-term disability; and
|
|
•
|
a Section 401(k) plan.
|
|
•
|
a short-term performance-based equity award in the form of shares of our common stock to be earned based on our consolidated revenue and adjusted EBITDA performance in 2014;
|
|
•
|
a long-term performance-based award in the form of shares of our common stock and restricted stock units to be earned based on 2014 annual performance and to vest in three equal annual increments in February 2015, 2016 and 2017; and
|
|
•
|
a long-term time-based equity award in the form of restricted stock units to be earned in three equal annual increments in February 2015, 2016 and 2017.
|
|
Value of STI Performance-Based Stock Bonus at Time of Grant
|
Value of LTI Performance-Based RSU Bonus at Time of Grant
|
Value of LTI Time-Based RSU Award at time of Grant
|
||||||||||||||||||||||
|
Target
|
Maximum
|
Target
|
Maximum
|
|
||||||||||||||||||||
|
|
$
|
700,000
|
|
|
|
$
|
1,400,000
|
|
|
|
$
|
700,000
|
|
|
|
$
|
1,400,000
|
|
|
|
$
|
700,000
|
|
|
|
•
|
The number of shares of our common stock that he is eligible to earn for target level performance remains 96,666 shares.
|
|
•
|
The number of shares of our common stock that he is eligible to earn for exceeding target level performance has been reduced from 96,999 shares to 48,333 shares.
|
|
•
|
Half of these shares are to be earned, if at all, based on leading certain strategic product-specific goals for 2014, such as innovating a scalable methodology to calculating metrics across multiple media platforms.
|
|
•
|
The remaining half of the shares are to be earned, if at all, based on the target levels for revenue and adjusted EBITDA established by our compensation committee for 2014. Our compensation committee established the revenue and adjusted EBITDA target levels for 2014 using a similar approach to its determination of the target levels for 2013.
|
|
•
|
a short-term performance-based equity award in the form of shares of our common stock to be earned based on our Company's revenue and adjusted EBITDA performance in 2014;
|
|
•
|
a long-term performance-based award in the form of shares of our common stock and restricted stock units to be earned based on 2014 annual performance and to vest in three equal annual increments in February 2015, 2016 and 2017; and
|
|
•
|
a long-term time-based equity award in the form of restricted stock units to be earned in three equal annual increments in February 2015, 2016 and 2017.
|
|
Value of STI Performance-Based Stock Bonus at Time of Grant
|
Value of LTI Performance-Based RSU Bonus at Time of Grant
|
Value of LTI Time-Based RSU Award at time of Grant
|
||||||||||||||||||||||
|
Target
|
Maximum
|
Target
|
Maximum
|
|
||||||||||||||||||||
|
|
$
|
265,000
|
|
|
|
$
|
530,000
|
|
|
|
$
|
450,000
|
|
|
|
$
|
900,000
|
|
|
|
$
|
300,000
|
|
|
|
Name and Principal Position
|
Year($)
|
Salary ($)
|
Stock Awards ($)(1)
|
All Other Compensation ($)
|
Total ($)
|
|
Magid M. Abraham, Ph.D.
President, Chief Executive Officer and Director* |
2013
2012
2011
|
$ 500,000(2)
500,008(5)
393,100(7)
|
$ 1,563,089(3)
6,673,052(6)
2,476,093(8)
|
$ 213(4)
176(4)
984(4)
|
$ 2,063,302
7,173,236
2,870,177
|
|
Kenneth J. Tarpey
Chief Financial Officer |
2013
2012
2011
|
363,125
341,249
311,250
|
1,525,138(9)
849,100(10)
294,064(11)
|
2,175(4)
3,785(4)
3,803(4)
|
1,890,438
1,194,134
609,117
|
|
Gian M. Fulgoni
Executive Chairman of the Board of Directors*
|
2013
2012
2011
|
375,000(12)
375,005(14)
346,000(16)
|
2,158,895(13)
1,001,600(15)
1,660,900(17)
|
359(4)
392(4)
392(4)
|
2,534,254
1,376,997
2,007,292
|
|
Serge Matta
President*
|
2013
2012
|
382,512
328,749
|
2,981,384(18)
1,098,484(19)
|
3,077(4)
3,557(4)
|
3,366,963
1,430,790
|
|
Cameron Meierhoefer
Chief Operating Officer
|
2013
2012
|
315,750
293,749
|
1,411,262(20)
1,025,600(21)
|
1,929(4)
1,207(4)
|
1,728,941
1,320,556
|
|
*
|
Mr. Matta became our President and Chief Executive Officer on March 1, 2014 and a member of our Board of Directors on April 15, 2014. Upon his appointment, Dr. Abraham became our Executive Chairman and Mr. Fulgoni became our Chairman Emeritus. The titles listed in the preceding table reflect the titles of these individuals as of the end of 2013.
|
|
(1)
|
Amounts represent the aggregate grant date fair value of awards or equity plan compensation computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation-Stock Compensation (FASB ASC Topic 718). Assumptions used in the calculation of these amounts are described in Note 10 to the consolidated financial statements included in Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2013.
|
|
(2)
|
Includes $484,000 computed in accordance with FASB ASC Topic 718, received in restricted stock units in lieu of cash salary from January 1, 2013 through December 31, 2013 with the remainder paid in cash during 2013 to cover health benefits.
|
|
(3)
|
Represents a performance-based award related to our 2012 Equity Incentive Plan granted on March 29, 2012, in restricted stock pursuant to the provisions of our 2012 CEO Bonus Policy, to vest over three equal annual tranches , based on performance targets established in the beginning of each measurement year. In 2013, performance criteria were approved by our Compensation Committee on April 30, 2013, with a fair value of $1,563,089 computed in accordance with FASB ASC Topic 718, to vest on March 30, 2014 upon achievement of pre-determined revenue and EBITDA milestones in 2013. On March 30, 2014, because we surpassed our pre-established consolidated revenue and adjusted EBITDA targets, 100% of these performance-based shares (or 96,666) vested, and an additional 65,620 performance-based restricted stock units vested with a vest date fair value of $5,160,263 computed in accordance with FASB ASC Topic 718 for over-achievement of pre-established goals. The table does not reflect the shares subject to 2014 performance, for which performance goals have not been established. For a description of this award see the "Compensation Discussion and Analysis- Additional Arrangements for Chief Executive Officer.”
|
|
(4)
|
Includes discretionary matching contributions by us to the officer’s 401(k) plan account and payment of life insurance premiums on behalf of the named executive officers.
|
|
(5)
|
Includes $484,008, computed in accordance with FASB ASC Topic 718, received in restricted stock units in lieu of cash salary from January 1, 2012 through December 31, 2012 with the remainder paid in cash during 2012 to cover health benefits.
|
|
(6)
|
Represents a performance-based award related to our 2012 Equity Incentive Plan granted on March 29, 2012, in restricted stock pursuant to the provisions of our 2012 CEO Bonus Policy, with a grant date fair value of $2,103,452 computed in accordance with FASB ASC Topic 718, to vest on March 30, 2013 upon achievement of pre-determined revenue and EBITDA milestones in 2012. On March 30, 2013, 100% of these performance-based shares were canceled due to failure to achieve pre-determined milestones during 2012. Also represents a grant to Dr. Abraham of 210,000 shares, awarded on March 29, 2012, made for retention purposes with vesting over a 4-year period in March 2013, 2014, 2015, and 2016 respectively.
|
|
(7)
|
Includes $393,100, computed in accordance with FASB ASC Topic 718, received in restricted stock units in lieu of cash salary from March 1, 2011 through December 31, 2011. For the period from March 1, 2011 through December 31, 2011, Dr. Abraham received payment of stock in lieu of cash salary.
|
|
(8)
|
Represents an award granted on April 28, 2011 in restricted stock units pursuant to the provisions of our 2011 Amended and Restated Executive Compensation Bonus Policy, with a grant date fair value of $2,476,093 computed in accordance with FASB ASC Topic 718. $1,232,827 of the total grant amount was converted to restricted stock in March 2012 based on the value of the short-term bonus and long-term bonus earned by him, as determined by the compensation committee on March 16, 2012, with 56.25% of the converted amount subject to vesting.
|
|
(9)
|
Amount represents a grant with a fair value of $336,617 in short-term performance-based incentive, and a grant with a fair value of $300,000 in long-term performance-based incentive with vesting through March 2016, and a retention award with a grant date fair value of $588,500, vesting over a 3-year period in February 2014, 2015 and 2016.
|
|
(10)
|
Amount represents a grant with a fair value of $21,875 in short-term performance-based incentive, and a grant with a fair value of $65,625 in long-term performance-based incentive with vesting through March 2015, and a retention award with a grant date fair value of $761,600, vesting over a 4-year period in March 2013, 2014, 2015 and 2016.
|
|
(11)
|
Represents awards of restricted stock according to certain target levels for each named executive officer pursuant to the provisions of our 2011 Amended and Restated Executive Compensation Bonus Policy. Awards under such policy relating to 2011 performance were paid in March 2012 following approval by our compensation committee, with 56.25% subject to vesting.
|
|
(12)
|
Includes $332,000 computed in accordance with FASB ASC Topic 718, received in restricted stock units in lieu of cash salary from January 1, 2013 through December 31, 2013 with the remainder paid in cash during 2013 to cover health benefits.
|
|
(13)
|
Amount represents a grant with a fair value of $470,357 in short-term performance-based incentive, and a grant with a fair value of $1,100,000 in long-term performance-based incentive with vesting through March 2016, and a retention award with a grant date fair value of $588,500, vesting over a 3-year period in February 2014, 2015 and 2016.
|
|
(14)
|
Includes $345,505 computed in accordance with FASB ASC Topic 718, received in restricted stock units in lieu of cash salary from January 1, 2013 through December 31, 2013 with the remainder paid in cash during 2013 to cover health benefits.
|
|
(15)
|
Amount represents a grant with a fair value of $60,000 in short-term performance-based incentive, and a grant with a fair value of $180,000 in long-term performance-based incentive with vesting through March 2015, and a retention award with a grant date fair value of $761,600, vesting over a 4-year period in March 2013, 2014, 2015 and 2016.
|
|
(16)
|
Includes $346,000 based on value at the time of the award, received in restricted stock units in lieu of cash salary from March 1, 2011 through December 31, 2011. For the period from March 1, 2011 through December 31, 2011, Mr. Fulgoni received payment of stock in lieu of cash salary.
|
|
(17)
|
Represents an award granted on April 28, 2011 in restricted stock units pursuant to the provisions of our 2011 Amended and Restated Executive Compensation Bonus Policy, with a grant date fair value of $1,660,882 computed in accordance with FASB ASC Topic 718. $826,888 of the total grant amount was converted to restricted stock in March 2012 based on the value of the short-term bonus and long-term bonus earned by him, as determined by the compensation committee on March 16, 2012, with 56.25% of the converted amount subject to vesting.
|
|
(18)
|
Amount represents a grant with a fair value of $604,374 in short-term performance-based incentive, and a grant with a fair value of $1,200,000 in long-term performance-based incentive with vesting through March 2016, and a retention award with a grant date fair value of $1,177,000, vesting over a 3-year period in February 2014, 2015 and 2016.
|
|
(19)
|
Amount represents a grant with a fair value of $84,221 in short-term performance-based incentive, and a grant with a fair value of $252,663 in long-term performance-based incentive, and a retention award with a grant date fair value of $761,600, vesting over a 4-year period in March 2013, 2014, 2015 and 2016.
|
|
(20)
|
Amount represents a grant with a fair value of $222,754 in short-term performance-based incentive, and a grant with a fair value of $300,000 in long-term performance-based incentive with vesting through March 2016, and a retention award with a grant date fair value of $588,500, vesting over a 3-year period in February 2014, 2015 and 2016.
|
|
(21)
|
Amount represents a grant with a fair value of $66,000 in short-term performance-based incentive, and a grant with a fair value of $198,000 in long-term incentive, and a retention award with a grant date fair value of $761,600, vesting over a 4-year period in March 2013, 2014, 2015 and 2016.
|
|
|
|
|
|
Estimated Future Payouts Under Equity Incentive Plan Awards (1)
|
|
All Other Stock Awards: Number of Shares of Stock (#)
|
|
Grant Date Fair Value of Stock and Option Awards($) (2)
|
|||||||||||
|
Name
|
|
Grant Date
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
||||||||||
|
Magid M. Abraham, Ph.D
|
|
3/29/2012
|
|
— (3)
|
|
96,666
|
(3)
|
|
193,332
|
(3)
|
|
—
|
|
$
|
5,160,263
|
|
|||
|
Kenneth J. Tarpey
|
|
6/19/2013
|
|
|
|
|
|
|
|
25,000
|
|
|
588,500
|
|
|||||
|
|
|
2/18/2014
|
|
—
|
|
$
|
725,625
|
|
|
$
|
1,151,250
|
|
|
—
|
|
936,638
|
|
||
|
Gian M. Fulgoni
|
|
6/19/2013
|
|
|
|
|
|
|
|
25,000
|
|
|
588,500
|
|
|||||
|
|
|
2/18/2014
|
|
—
|
|
$
|
1,200,000
|
|
|
$
|
1,850,000
|
|
|
—
|
|
1,570,394
|
|
||
|
Serge Matta
|
|
6/19/2013
|
|
|
|
|
|
|
|
50,000
|
|
|
1,177,000
|
|
|||||
|
|
|
2/18/2014
|
|
—
|
|
$
|
1,315,000
|
|
|
$
|
2,030,000
|
|
|
—
|
|
1,804,384
|
|
||
|
Cameron Meierhoefer
|
|
6/19/2013
|
|
|
|
|
|
|
|
25,000
|
|
|
588,500
|
|
|||||
|
|
|
2/18/2014
|
|
—
|
|
$
|
690,750
|
|
|
$
|
1,081,500
|
|
|
—
|
|
822,762
|
|
||
|
(1)
|
The target and maximum incentive amounts shown in this column reflect the value of the short- and long-term incentive compensation available to our named executive officers pursuant to our 2013 executive incentive compensation policy. The amounts representing the target awards were pre-established as a percentage of salary. The maximum is the greatest payout which can be made if the pre-established maximum performance level is met or exceeded. The policy also provides that the entire bonus amount shall be paid in shares of restricted stock valued at the time of grant. Actual awards under our 2013 executive short- and long-term compensation policy were approved on February 18, 2014 and are reflected in the Stock Award column of the Summary Compensation Table above for 2013 in each case for each named executive officer.
|
|
(2)
|
Amounts represent fair value of awards granted in the fiscal year as calculated in accordance with FASB ASC Topic 718 and as further described in Note 10 to the consolidated financial statements included in Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2013.
|
|
(3)
|
On March 29, 2012, Dr. Abraham was awarded 580,000 shares of our common stock in the form of restricted stock and restricted stock units that vest based on achievement of revenue and adjusted EBITDA goals during 2012, 2013 and 2014. Assuming achievement of 100% of the target performance metrics in each case over a three-year period, Dr. Abraham would be eligible to vest in 290,000 total shares, and in any given year 96,666 shares. Assuming achievement of 200% of the target performance metrics in each case over a three-year period, the maximum number permitted under the arrangement, Dr. Abraham is eligible to vest in 580,000 total shares, and in any given year, 193,332 shares.
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||||||||
|
|
|
Number of Securities Underlying Unexercised Options (#)
|
|
Option Exercise
Price ($)
|
|
Option Expiration
Date
|
|
Number of Shares of Stock That Have Not Vested
(#)(1)
|
|
Market Value of Shares of Stock That Have Not Vested
($)(1)
|
||||
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
|||||||||
|
Magid M. Abraham, Ph.D.
|
|
|
|
|
|
|
|
|
|
19,962
|
(2)
|
|
571,113
|
|
|
|
|
|
|
|
|
|
|
|
|
140,000
|
(2)
|
|
4,005,400
|
|
|
|
|
|
|
|
|
|
|
|
|
386,664
|
(2)
|
|
2,765,643
|
|
|
|
|
|
|
|
|
|
|
|
|
8,694
|
(5)
|
|
248,735
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Kenneth J. Tarpey
|
|
|
|
|
|
|
|
|
|
4,762
|
(2)
|
|
136,241
|
|
|
|
|
|
|
|
|
|
|
|
|
26,250
|
(2)
|
|
751,013
|
|
|
|
|
|
|
|
|
|
|
|
|
2,524
|
(2)
|
|
72,212
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
(2)
|
|
715,250
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
(2)
|
|
143,050
|
|
|
|
|
|
|
|
|
|
|
|
|
4,147
|
(2)
|
|
118,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Gian M. Fulgoni
|
|
|
|
|
|
|
|
|
|
13,390
|
(2)
|
|
383,088
|
|
|
|
|
|
|
|
|
|
|
|
|
26,250
|
(2)
|
|
751,013
|
|
|
|
|
|
|
|
|
|
|
|
|
6,921
|
(2)
|
|
198,010
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
(2)
|
|
715,250
|
|
|
|
|
|
|
|
|
|
|
|
|
6,137
|
(2)
|
|
175,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Serge Matta
|
|
|
|
|
|
|
|
|
|
5,000
|
(2)
|
|
143,050
|
|
|
|
|
|
|
|
|
|
|
|
|
4,536
|
(2)
|
|
129,775
|
|
|
|
|
|
|
|
|
|
|
|
|
26,250
|
(2)
|
|
751,013
|
|
|
|
|
|
|
|
|
|
|
|
|
9,715
|
(2)
|
|
277,946
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
(2)
|
|
1,430500
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
(2)
|
|
429,150
|
|
|
|
|
|
|
|
|
|
|
|
|
1,858
|
(2)
|
|
53,157
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Cameron Meierhoefer
|
|
|
|
|
|
|
|
|
|
3,084
|
(2)
|
|
88,233
|
|
|
|
|
|
|
|
|
|
|
|
|
26,250
|
(2)
|
|
751,013
|
|
|
|
|
|
|
|
|
|
|
|
|
7,613
|
(2)
|
|
217,808
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
(2)
|
|
715,250
|
|
|
|
|
|
|
|
|
|
|
|
|
3,750
|
(2)
|
|
107,288
|
|
|
|
|
|
|
|
|
|
|
|
|
1,839
|
(2)
|
|
52,614
|
|
|
(1)
|
Market value of shares of stock that have not vested is computed based on $28.61 per share, which was the closing price of our common stock as reported on the NASDAQ Global Market on December 31, 2013. For a description of this award see the Compensation Discussion and Analysis section titled “Additional Arrangements for Chief Executive Officer.”
|
|
(2)
|
comScore’s right of repurchase lapses for 9,981 shares annually on March 29, contingent upon Dr. Abraham’s continued service as of each such dates.
|
|
(3)
|
comScore’s right of repurchase lapses for 70,000 shares annually on March 29, contingent upon Dr. Abraham’s continued service as of each such dates.
|
|
(4)
|
On March 29, 2012, Dr. Abraham was awarded 580,000 shares of our common stock in the form of restricted stock and restricted stock units that vest based on achievement of revenue and adjusted EBITDA goals during 2012, 2013 and 2014. In 2014, Dr. Abraham becomes eligible to earn up to 96,666 shares for achieving 100% of pre-established revenue and EBITDA targets. In 2014, this award was adjusted to reflect Dr. Abraham's change in role to Executive Chairman. As a result, in 2014, Dr. Abraham is eligible to earn up to 96,666 shares for achieving 100% of pre-established revenue, EBITDA, and product-specific goals, and an additional 48,333 shares for overachieving against pre-established revenue, EBITDA, and product development targets. Any unearned shares from prior years have been canceled.
|
|
(5)
|
comScore’s right of repurchase lapses for 8,694 shares annually on February 18, contingent upon Dr. Abraham’s continued service as of each such dates
|
|
(6)
|
comScore’s right of repurchase lapses for 2,381 shares annually on March 15, contingent upon Mr. Tarpey’s continued service as of each such dates.
|
|
(7)
|
comScore’s right of repurchase lapses for 8,750 shares annually on March 15, contingent upon Mr. Tarpey’s continued service as of each such dates.
|
|
(8)
|
Restricted stock unit awards with 1,262 shares vesting annually on March 15, contingent upon Mr. Tarpey’s continued service as of each such dates.
|
|
(9)
|
Restricted stock unit awards with 8,333 shares vesting annually on February 18 contingent upon Mr. Tarpey’s continued service as of each such dates.
|
|
(10)
|
comScore’s right of repurchase lapses for 5,000 shares annually on February 18, contingent upon Mr. Tarpey’s continued service as of each such dates.
|
|
(11)
|
comScore’s right of repurchase lapses for 4,147 shares annually on February 18, contingent upon Mr. Tarpey’s continued service as of each such dates
|
|
(12)
|
comScore’s right of repurchase lapses for 6,694 shares annually on March 15, contingent upon Mr. Fulgoni’s continued service as of each such dates.
|
|
(13)
|
comScore’s right of repurchase lapses for 8,750 shares annually on March 15, contingent upon Mr. Fulgoni’s continued service as of each such dates.
|
|
(14)
|
Restricted stock unit awards with 3,460 shares vesting annually on March 15, contingent upon Mr. Fulgoni’s continued service as of each such dates.
|
|
(15)
|
Restricted stock unit awards with 8,333 shares vesting annually on February 18, contingent upon Mr. Fulgoni’s continued service as of each such dates.
|
|
(16)
|
comScore’s right of repurchase lapses for 6,137 shares annually on February 18, contingent upon Mr. Fulgoni’s continued service as of each such dates.
|
|
(17)
|
comScore’s right of repurchase lapses for 5,000 shares annually on August 15, contingent upon Mr. Matta’s continued service as of each such dates.
|
|
(18)
|
comScore’s right of repurchase lapses for 2,268 shares annually on March 15, contingent upon Mr. Matta’s continued service as of each such dates.
|
|
(19)
|
comScore’s right of repurchase lapses for 8,750 shares annually on March 15, contingent upon Mr. Matta’s continued service as of each such dates.
|
|
(20)
|
Restricted stock unit awards with 4,857 shares vesting annually on March 15, contingent upon Mr. Matta’s continued service as of each such dates.
|
|
(21)
|
Restricted stock unit awards with 16,667 shares vesting annually on February 18, contingent upon Mr. Matta’s continued service as of each such dates.
|
|
(22)
|
comScore’s right of repurchase lapses for 7,500 shares annually on February 18, contingent upon Mr. Matta’s continued service as of each such dates.
|
|
(23)
|
comScore’s right of repurchase lapses for 1,858 shares annually on February 18, contingent upon Mr. Matta’s continued service as of each such dates
|
|
(24)
|
comScore’s right of repurchase lapses for 1,542 shares annually on March 15, contingent upon Mr. Meierhoefer’s continued service as of each such dates.
|
|
(25)
|
comScore’s right of repurchase lapses for 8,750 shares annually on March 15, contingent upon Mr. Meierhoefer’s continued service as of each such dates.
|
|
(26)
|
Restricted stock unit awards with 3,806 shares vesting annually on March 15, contingent upon Mr. Meierhoefer’s continued service as of each such dates.
|
|
(27)
|
Restricted stock unit awards with 8,333 shares vesting annually on February 18, contingent upon Mr. Meierhoefer’s continued service as of each such dates.
|
|
(28)
|
comScore’s right of repurchase lapses for 3,750 shares annually on February 18, contingent upon Mr. Meierhoefer’s continued service as of each such dates
|
|
(29)
|
comScore’s right of repurchase lapses for 1,839 shares annually on February 18, contingent upon Mr. Meierhoefer’s continued service as of each such dates.
|
|
Name
|
|
Option Awards
|
|
Stock Awards
|
||||||||
|
|
Number of Shares Acquired on
Exercise (#)
|
|
Value Realized on Exercise
($)(1)
|
|
Number of Shares Acquired on
Vesting (#)
|
|
Value Realized
on Vesting ($)
|
|||||
|
Magid M. Abraham, Ph.D.
|
|
—
|
|
|
—
|
|
|
18,035
|
|
|
293,069
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
13,307
|
|
|
216,239
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
8,694
|
|
|
141,278
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
9,981
|
|
|
173,071
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
70,000
|
|
|
1,174,600
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
35,124
|
|
|
484,009
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
13,586
|
|
|
363,018
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
4,230
|
|
|
121,020
|
(2)
|
|
|
|
|
|
|
|
|
|
|
||||
|
Kenneth J. Tarpey
|
|
—
|
|
|
—
|
|
|
21,250
|
|
|
335,113
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
4,127
|
|
|
67,064
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
5,000
|
|
|
81,250
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
4,146
|
|
|
67,373
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
2,381
|
|
|
41,287
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
8,750
|
|
|
151,725
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
2,524
|
|
|
43,766
|
(2)
|
|
|
|
|
|
|
|
|
|
|
||||
|
Gian M. Fulgoni
|
|
—
|
|
|
—
|
|
|
12,008
|
|
|
195,130
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
9,393
|
|
|
152,636
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
6,137
|
|
|
99,726
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
6,694
|
|
|
116,074
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
8,750
|
|
|
151,725
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
25,073
|
|
|
345,506
|
(5)
|
|
|
|
—
|
|
|
—
|
|
|
6,921
|
|
|
120,010
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
9,319
|
|
|
249,004
|
(6)
|
|
|
|
—
|
|
|
—
|
|
|
2,902
|
|
|
83,026
|
(7)
|
|
|
|
|
|
|
|
|
|
|
||||
|
Serge Matta
|
|
—
|
|
|
—
|
|
|
3,983
|
|
|
64,724
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
2,971
|
|
|
48,279
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
5,000
|
|
|
141,000
|
(9)
|
|
|
|
—
|
|
|
—
|
|
|
7,500
|
|
|
121,875
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
1,857
|
|
|
30,176
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
2,165
|
|
|
37,541
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
8,750
|
|
|
151,725
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
9,715
|
|
|
168,458
|
(2)
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cameron Meierhoefer
|
|
—
|
|
|
—
|
|
|
3,000
|
|
|
48,750
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
2,734
|
|
|
44,428
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
3,750
|
|
|
60,938
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
1,839
|
|
|
29,884
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
1,472
|
|
|
25,524
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
8,750
|
|
|
151,725
|
(2)
|
|
|
|
—
|
|
|
—
|
|
|
7,613
|
|
|
132,009
|
(2)
|
|
(1)
|
The value realized on exercise is calculated as the difference between the actual sales price of the shares underlying the options exercised and the applicable exercise price of those options.
|
|
(2)
|
The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $16.25 per share at market close as listed by the NASDAQ Global Market on February 18, 2013.
|
|
(3)
|
The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $17.34 per share at market close as listed by the NASDAQ Global Market on March 15, 2013.
|
|
(4)
|
The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $16.78 per share at market close as listed by the NASDAQ Global Market on March 30, 2013.
|
|
(5)
|
The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $13.78 per share at market close as listed by the NASDAQ Global Market on January 1, 2013.
|
|
(6)
|
The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $26.72 per share at market close as listed by the NASDAQ Global Market on October 31, 2013.
|
|
(7)
|
The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $28.61 per share at market close as listed by the NASDAQ Global Market on December 31, 2013.
|
|
(8)
|
The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $15.77 per share at market close as listed by the NASDAQ Global Market on April 20, 2013.
|
|
(9)
|
The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $28.20 per share at market close as listed by the NASDAQ Global Market on August 15, 2013.
|
|
•
|
payment of all accrued but unpaid vacation, expense reimbursements, wages and other benefits due under our plans, policies and arrangements;
|
|
•
|
continuing payments at a rate equal to his annual base salary then in effect, for the duration of a specified severance period (as identified in the table below for each such named executive officer), to be paid periodically in accordance with our normal payroll policies; and
|
|
•
|
reimbursement of COBRA premiums (or an equivalent cash distribution if his severance period exceeds the permitted COBRA participation period) until the earlier of the expiration of the specified severance period or the date that he becomes covered under a similar plan.
|
|
Name and Principal Position
|
|
Severance Period
|
|
Magid M. Abraham, Ph.D.
President, Chief Executive Officer and Director
|
|
2 years
|
|
Kenneth J. Tarpey
Chief Financial Officer
|
|
1.25 years
|
|
Gian M. Fulgoni
Executive Chairman of the Board of Directors
|
|
1.5 years
|
|
Serge Matta(1)
President
|
|
1 year
|
|
Cameron Meierhoefer
Chief Operating Officer
|
|
1 year
|
|
(1)
|
Effective on March 1, 2014, Mr. Matta's severance period was revised to 2 years.
|
|
•
|
payment of all accrued but unpaid vacation, expense reimbursements, wages and other benefits due under our plans, policies and arrangements;
|
|
•
|
a lump sum payment (less applicable withholding taxes) equal to a specified change in control multiple (as identified in the chart below for each such named executive officer) multiplied by his annual base salary in effect immediately prior to his termination date or, if greater, at the level in effect immediately prior to the change in control; and
|
|
•
|
reimbursement of COBRA premiums (or an equivalent cash distribution if his severance period exceeds the permitted COBRA participation period) until the earlier of the expiration of a specified severance period (as identified in the table above for each such named executive officer) or the date that such he becomes covered under a similar plan.
|
|
Name and Principal Position
|
|
Change of Control Multiple
|
|
Magid M. Abraham, Ph.D.
President, Chief Executive Officer and Director
|
|
2x
|
|
Kenneth J. Tarpey
Chief Financial Officer
|
|
1.25x
|
|
Gian M. Fulgoni
Executive Chairman of the Board of Directors
|
|
1.5x
|
|
Serge Matta(1)
President
|
|
1x
|
|
Cameron Meierhoefer
Chief Operating Officer
|
|
1x
|
|
(1)
|
Effective on March 1, 2014, Mr. Matta's change of control multiple was revised to 2x.
|
|
Name
|
|
Market Value of Accelerated Equity (net of exercise price, if any)(1)
|
|
Magid M. Abraham, Ph.D.
|
|
$ 15,887,705(2)(4)
|
|
Kenneth J. Tarpey
|
|
—(3)
|
|
Gian M. Fulgoni
|
|
2,222,940(2)
|
|
Serge Matta
|
|
—(3)
|
|
Cameron Meierhoefer
|
|
—(3)
|
|
(1)
|
Based on an assumed fair market value per share of our common stock of $28.61, which was the closing price of our common stock as reported by the NASDAQ Global Market on December 31, 2013.
|
|
(2)
|
Dr. Abraham and Mr. Fulgoni are parties to Severance and Change of Control Agreements whereby each named executive officer’s outstanding and unvested equity awards become vested in full upon a change of control of comScore.
|
|
(3)
|
Each of the agreements with Messrs. Tarpey, Matta and Meierhoefer provides that if each such named executive officer remains employed by or continues to provide services to us through the one-year anniversary of a change of of comScore, all of such named executive officer’s outstanding and unvested equity awards become vested in full.
|
|
(4)
|
The referenced amount includes the acceleration of 193,333 unvested performance-based restricted stock and restricted stock units held by Dr. Abraham as of December 31, 2013. Of such amount, 31,416 restricted stock units related to overachievement of pre-established targets were subsequently canceled in 2014 as the components of 2013 performance awards did not satisfy the vesting criteria required to earn such shares. Excluding these shares, the market value of accelerating the outstanding and unvested equity awards of Dr. Abraham as of December 31, 2013 would have been $14,988,893.
|
|
|
|
Cash Payments
|
|
Market Value of Accelerated Equity (net of exercise price, if any)(3)
|
|||||||
|
Name
|
|
Salary(1)
|
|
COBRA/ Insurance(2)
|
|
||||||
|
Magid M. Abraham, Ph.D.
|
|
$
|
1,000,000
|
|
|
$
|
42,829
|
|
|
$ 16,930,534(4)(5)
|
|
|
Kenneth J. Tarpey
|
|
458,750
|
|
|
26,768
|
|
|
—
|
|
||
|
Gian M. Fulgoni
|
|
562,500
|
|
|
31,708
|
|
|
2,817,148(4)
|
|
||
|
Serge Matta
|
|
415,000
|
|
|
21,415
|
|
|
—
|
|
||
|
Cameron Meierhoefer
|
|
300,000
|
|
|
21,415
|
|
|
—
|
|
||
|
(1)
|
Salary to be paid at a rate equal to such named executive officer’s annual base salary then in effect, for the duration of a specified severance period, to be paid periodically in accordance with our normal payroll policies.
|
|
(2)
|
COBRA/Insurance payments are estimated based on the number of months of coverage for which we are contractually obligated and the current estimated premium costs.
|
|
(3)
|
Based on an assumed fair market value per share of our common stock of $28.61, which was the closing price of our common stock as reported by the NASDAQ Global Market on December 31, 2013.
|
|
(4)
|
Dr. Abraham and Mr. Fulgoni are parties to Severance and Change of Control Agreements whereby each named executive officer’s outstanding and unvested equity awards become vested in full upon a termination of employment without cause or by the named executive officer for good reason.
|
|
(5)
|
The referenced amount includes the acceleration of 193,333 unvested performance-based restricted stock and restricted stock units held by Dr. Abraham as of December 31, 2013. Of such amount, 31,416 restricted stock units related to overachievement of pre-established targets were subsequently canceled in 2014 as the components of 2013 performance awards did not satisfy the vesting criteria required to earn such shares. Excluding these shares, the market value of accelerating the outstanding and unvested equity awards of Dr. Abraham as of December 31, 2013 would have been $14,988,893.
|
|
|
|
Cash Payments
|
|
Market Value of Accelerated Equity(net of exercise price, if any)(3)
|
||||||||
|
Name
|
|
Salary(1)
|
|
COBRA/ Insurance(2)
|
|
|||||||
|
Magid M. Abraham, Ph.D.
|
|
$
|
1,000,000
|
|
|
$
|
42,829
|
|
|
$
|
16,930,534
|
(4)(6)
|
|
Kenneth J. Tarpey
|
|
437,500
|
|
|
26,768
|
|
|
2,400,679(5)
|
|
|||
|
Gian M. Fulgoni
|
|
562,500
|
|
|
31,708
|
|
|
2,817,148(4)
|
|
|||
|
Serge Matta
|
|
335,000
|
|
|
21,415
|
|
|
4,739,276(5)
|
|
|||
|
Cameron Meierhoefer
|
|
300,000
|
|
|
21,415
|
|
|
2,730,463(5)
|
|
|||
|
(1)
|
Gross amount of lump sum payment (prior to payment of applicable withhold taxes).
|
|
(2)
|
COBRA/Insurance payments are estimated based on the number of months of coverage for which we are contractually obligated and the current estimated premium costs.
|
|
(3)
|
Based on an assumed fair market value per share of our common stock of $28.61, which was the closing price of our common stock as reported by the NASDAQ Global Market on December 31, 2013.
|
|
(4)
|
Dr. Abraham and Mr. Fulgoni are parties to Severance and Change of Control Agreements whereby each named executive officer’s outstanding and unvested equity awards become vested in full upon a change in control of comScore.
|
|
(5)
|
Each of the agreements with Messrs. Tarpey, Matta and Meierhoefer provides that if each such named executive officer remains employed by or continues to provide services to us through the one-year anniversary of a change in control of comScore, all of such named executive officer’s outstanding and unvested equity awards become vested in full.
|
|
(6)
|
The referenced amount includes the acceleration of 193,333 unvested performance-based restricted stock and restricted stock units held by Dr. Abraham as of December 31, 2013. Of such amount, 31,416 restricted stock units related to overachievement of pre-established targets were subsequently canceled in 2014 as the components of 2013 performance awards did not satisfy the vesting criteria required to earn such shares. Excluding these shares, the market value of accelerating the outstanding and unvested equity awards of Dr. Abraham as of December 31, 2013 would have been $14,988,893.
|
|
•
|
each beneficial owner of 5% or more of the outstanding shares of our common stock;
|
|
•
|
each of our directors;
|
|
•
|
each of our named executive officers; and
|
|
•
|
all of our executive officers and directors as a group.
|
|
Name and Address of Beneficial Owner
|
|
Amount and Nature of Beneficial Ownership(1)
|
|
Percentage of Common Stock Outstanding
|
||
|
5% or Greater Stockholders:
|
|
|
|
|
||
|
PRIMECAP Management Company(2)
|
|
3,607,532
|
|
|
10.1
|
%
|
|
Cadian Capital Management, LLC(3)
|
|
3,570,268
|
|
|
10.0
|
|
|
Blackrock, Inc.(4)
|
|
3,032,388
|
|
|
8.5
|
|
|
The Vanguard Group(5)
|
|
2,344,117
|
|
|
6.6
|
|
|
Sageview Capital Master, L.P.(6)
|
|
1,783,893
|
|
|
5.0
|
|
|
Directors, Director Nominees and Named Executive Officers:
|
|
|
|
|
||
|
Magid M. Abraham, Ph.D.(7)
|
|
200,211
|
|
|
*
|
|
|
Gian M. Fulgoni(8)
|
|
457,156
|
|
|
1.3
|
|
|
Kenneth J. Tarpey(9)
|
|
84,191
|
|
|
*
|
|
|
Serge Matta(10)
|
|
84,936
|
|
|
*
|
|
|
Cameron Meierhoefer(11)
|
|
51,286
|
|
|
*
|
|
|
Jeffrey Ganek(12)
|
|
27,817
|
|
|
*
|
|
|
William J. Henderson(12)
|
|
68,948
|
|
|
*
|
|
|
William Katz(12)
|
|
25,517
|
|
|
*
|
|
|
Ronald J. Korn(13)
|
|
41,748
|
|
|
*
|
|
|
Jarl Mohn(12)
|
|
25,517
|
|
|
*
|
|
|
Russell Fradin
|
|
-
|
|
|
*
|
|
|
All directors, director nominees and executive officers as a group (twelve persons)(14)
|
|
1,151,444
|
|
|
3.2
|
%
|
|
*
|
Represents less than 1% of the outstanding shares of common stock.
|
|
(1)
|
The information provided in this table is based on our records, information supplied to us by our executive officers, directors and principal stockholders and information contained in Schedules 13D and 13G filed with the SEC.
|
|
(2)
|
This information is derived solely from the Schedule 13D/A filed with the SEC on February 14, 2014. PRIMECAP Management Company has sole voting power over 2,828,260 shares and sole dispositive power of 3,607,532 shares. The address for PRIMECAP Management Company is 225 South Lake Ave., #400, Pasadena, CA 91101.
|
|
(3)
|
This information is derived solely from the Schedule 13G/A filed with the SEC on January 6, 2014. Cadian Capital Management, LLC has shared voting power and shared dispositive power over 3,5710,268 shares. Eric Bannasch has shared voting and shared dispositive power over 3,570,268 shares. Cadian Master Fund, LP has shared voting dispositive power over 1,731,580 shares. Cadian Fund, LP has shared voting and dispositive power over 1,838,688
|
|
(4)
|
This information is derived solely from the Schedule 13G/A filed with the SEC on January 28, 2014. BlackRock, Inc. on behalf of its investment advisory subsidiaries has sole voting power as to 2,923,853 shares and sole dispositive power as to 3,032,388 shares. Includes shares reportedly held by the following subsidiaries of Blackrock, Inc. that are investment advisors: BlackRock Advisors (UK) Limited, BlackRock Advisors, LLC, BlackRock Asset Management Canada Limited, BlackRock Asset Management Ireland Limited, BlackRock Fund Advisors*, BlackRock Institutional Trust Company, N.A., BlackRock International Limited, BlackRock Investment Management (Australia) Limited, BlackRock Investment Management (UK) Ltd, and BlackRock Investment Management, LLC. The address for Blackrock, Inc. and its subsidiaries is c/o Blackrock, Inc., 40 East 52nd Street, New York, New York 10022.
|
|
(5)
|
This information is derived solely from the Schedule 13G/A filed with the SEC on February 12, 2014. The Vanguard Group has sole voting power of 49,268 shares, sole dispositive power of 2,296,449 shares, and shared dispositive power of 47,668 shares. The address for the Vanguard Group is 100 Vanguard Blvd, Malvern, PA 19355.
|
|
(6)
|
This information is derived solely from the Schedule 13D/A filed with the SEC on January 8, 2014. Sageview Capital Master, L.P. has sole voting and dispositive power over 1,783,893 shares. Each of Sageview Capital Partners (A), L.P., Sageview Capital Partners (B), L.P., Sageview Partners (C) (Master), L.P., Sageview Capital GenPar, Ltd., Sageview Capital MGP, LLC, Sageview Capital, L.P., Edward A. Gilhuly and Scott M. Stuart has shared voting and dispositive power over 1,783,893 shares. The address of Sageview Capital Master, L.P. and its affiliates is 55 Railroad Road, Greenwich, CT 06830.
|
|
(7)
|
Includes 79,981 shares held directly by Dr. Abraham and subject to a right of repurchase held by us pursuant to restricted stock agreements; and 59,707 shares held by Mrs. Abraham with 14,276 shares held by Mrs. Abraham subject to a right of repurchase held by us pursuant to restricted stock agreements.
|
|
(8)
|
Includes 24,195 shares subject to a right of repurchase held by us pursuant to a restricted stock agreement.
|
|
(9)
|
Includes 19,881 shares subject to a right of repurchase held by us pursuant to a restricted stock agreement.
|
|
(10)
|
Includes 417 shares subject to options that are immediately exercisable or exercisable within 60 days of March 31, 2014. Additionally includes 32,368 shares subject to a right of repurchase held by us pursuant to a restricted stock agreement.
|
|
(11)
|
Includes 19,042 shares subject to a right of repurchase held by us pursuant to a restricted stock agreement.
|
|
(12)
|
Includes 4,725 shares that are subject to a right of repurchase held by us pursuant to a restricted stock agreement.
|
|
(13)
|
Includes 4,000 shares subject to options that are immediately exercisable or exercisable within 60 days of March 31, 2014. Additionally, includes 4,725 shares held directly by Mr. Korn that are subject to a right of repurchase held by us pursuant to a restricted stock agreement.
|
|
(14)
|
Includes 14,417 shares subject to options that are immediately exercisable or exercisable within 60 days of the March 31, 2013. Also includes 203,895 shares subject to a right of repurchase held by us pursuant to restricted stock agreements.
|
|
Date Filed
|
|
Form
|
|
Name(s) of Filer(s)
|
|
Description
|
|
March 7, 2013
|
|
4
|
|
Jeffery Ganek
William Henderson
William Katz
Ron Korn
Jarl Mohn
|
|
Filing related to transaction originally occurring on February 18, 2013.
|
|
March 22, 2013
|
|
4/A
|
|
Kenneth Tarpey
|
|
Amended Form 4 related to transaction originally occurring on March 15, 2013.
|
|
May 2, 2013
|
|
4
|
|
Kenneth Tarpey
|
|
Filing related to transaction originally occurring on April 29, 2013.
|
|
November 12, 2013
|
|
4
|
|
Magid Abraham
Gian Fulgoni
|
|
Filing related to transaction originally occurring on October 31, 2013.
|
|
Name
|
2012
|
2013
|
||||
|
Audit Fees(1)
|
$
|
1,829,488
|
|
$
|
1,768,500
|
|
|
Audit-Related Fees
|
-
|
|
-
|
|
||
|
Tax Fees
|
-
|
|
-
|
|
||
|
All Other Fees
|
_________-_
|
|
_________-_
|
|
||
|
Total Fees
|
$
|
1,829,488
|
|
$
|
1,768,500
|
|
|
(1)
|
Audit fees represent fees for professional services relating to the audit of our financial statements included in our annual reports on Form 10-K and our registration statements on Forms S-3 and S-8, the audit of internal control over financial reporting required by Section 404 of the Sarbanes-Oxley Act of 2002 and the review of the financial statements included in our quarterly reports on Form 10-Q.
|
|
•
|
reviewed and discussed our company’s audited financial statements with management and Ernst & Young LLP, the company’s independent registered public accounting firm;
|
|
•
|
discussed with Ernst & Young LLP the matters required to be discussed by Auditing Standard No. 16,
Communications with Audit Committees
, as currently in effect and as adopted by the Public Company Accounting Oversight Board; and
|
|
•
|
received from Ernst & Young LLP, disclosures and a letter regarding their independence as required the applicable requirements of the Public Company Accounting Oversight Board requesting Ernst & Young LLP’s communication with the audit committee concerning independence and discussed the auditors’ independence with them.
|
|
•
|
Magid Abraham,
|
|
•
|
Russel Fradin, and
|
|
•
|
William Katz
|
|
•
|
develop a culture that embodies a passion for our business and a drive to achieve and exceed established goals and objectives;
|
|
•
|
provide leadership to the organization in such a way as to maximize the results of our business operations;
|
|
•
|
lead us by demonstrating forward thinking in the operation, development and expansion of our business; and
|
|
•
|
effectively manage organizational resources to derive the greatest value possible from each dollar invested.
|
|
•
|
the name, mailing address and telephone number of the security holder sending the communication;
|
|
•
|
the number and type of our securities owned by such security holder; and
|
|
•
|
if the security holder is not a record owner of our securities, the name of the record owner of our securities beneficially owned by the security holder.
|
|
|
|
|||||||||||
|
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE ELECTION OF ALL
OF THE NOMINEES FOR PROPOSAL 1, “FOR” PROPOSAL 2 AND “FOR” PROPOSAL 3.
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE
|
x
|
|||||||||||
|
1.
|
To elect three (3) Class I members of the board of directors to serve until the 2017 annual meeting of stockholders
|
|||||||||||
|
|
|
NOMINEES:
|
||||||||||
|
¨
|
FOR ALL NOMINEES
|
¡
|
Magid M. Abraham
|
|||||||||
|
¨
|
WITHHOLD AUTHORITY FOR ALL NOMINEES
|
¡
|
Russell Fradin
|
|||||||||
|
¨
|
FOR ALL EXCEPT
(See Instructions below)
|
¡
|
William Katz
|
|||||||||
|
INSTRUCTIONS:
To withhold authority to vote for any individual nominee(s), mark
“FOR ALL EXCEPT”
and fill in the circle next to each nominee you wish to withhold, as shown here:
=
|
||||||||||||
|
2.
|
To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014:
|
3.
|
Advisory vote to approve compensation awarded to named executive officers in 2013:
|
|||||||||
|
¨
|
FOR
|
¨
|
FOR
|
|||||||||
|
¨
|
AGAINST
|
¨
|
AGAINST
|
|||||||||
|
¨
|
ABSTAIN
|
¨
|
ABSTAIN
|
|||||||||
|
|
|
|
|
|||||||||
|
THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN. IF NO SPECIFICATION IS MADE, THIS PROXY WILL BE VOTED “FOR” THE ELECTION OF ALL DIRECTOR NOMINEES LISTED IN PROPOSAL 1 HEREIN, “FOR” EACH OF PROPOSALS 2 AND 3 HEREIN AND AS SAID PROXIES DEEM ADVISABLE IN THEIR DISCRETION ON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE MEETING OR MAY OTHERWISE BE ALLOWED TO BE CONSIDERED AT THE MEETING.
|
||||||||||||
|
IN ORDER TO ASSURE YOUR REPRESENTATION AT THE ANNUAL MEETING OF STOCKHOLDERS, PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY IN THE ENCLOSED ENVELOPE.
|
||||||||||||
|
|
||||||||||||
|
|
||||||||||||
|
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
o
|
|||||||||||
|
|
||||||||||||
|
|
||||||||||||
|
Signature of Stockholder:
|
|
Date:
|
|
Signature of Stockholder:
|
|
Date:
|
|
|||||
|
|
||||||||||||
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
|||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|